infection rather than sepsis at the time of birth, with the average age of onset of infection being 26.2 days in one study of 155 infants. 10, 20, 21 In infants without gastroschisis, who are at risk for early onset infection, changes in inflammatory biomarkers can be helpful in determining the need for antibiotic treatment. However, there is a substantial knowledge gap regarding the reliability of inflammatory markers in infants with gastroschisis. Even in the absence of true infection, there are multiple factors in gastroschisis patients such as surgical closure, bowel ischemia, exposure to amniotic fluid, and other external environmental factors (i.e. air, surgical silo, gauze, and manual manipulation) that may influence infection markers. While several biomarkers are available for clinical and research use, only C-reactive protein (CRP) has been evaluated in infants with gastroschisis. However, this study concluded that it is not a reliable predictor of infection in these patients. 22 Thus, without a reliable biomarker for evaluation of infection in infants with gastroschisis, we questioned whether the more traditional tests, such as complete blood count (CBC) and the immature to mature neutrophil count (I:T ratio), might predict the risk of early onset infection risk in gastroschisis patients. Presently, there are no published reference values for inflammatory markers in infants with abdominal wall defects. Furthermore, there has been little research evaluating the need for antibiotic treatment in the immediate post-natal period of these infants. The primary purpose of this study is to evaluate the risk of early onset sepsis as well as the reliability of the CBC and I:T ratio in infants with gastroschisis. The secondary aim is to evaluate the antibiotic use trends in this population overall and in relation to the results of the CBC.
Methods

Study Population
The study's gastroschisis population was obtained through two hospital systems, Orlando Health's Winnie Palmer Hospital (WPH) and Cincinnati Children's Hospital Medical Center (CCHMC). The Arnold Palmer Hospital for Children Institutional Review Board and Cincinnati Children's Hospital Medical Center Institutional Review Board each approved the study. Infants born with gastroschisis between January 1, 2010 and December 31, 2015 were identified using the key word Gastroschisis in the electronic database BabySteps at WPH and a de-identified gastroschisis database at CCHMC. All infants identified were eligible for inclusion in the study.
A de-identified weight-matched non-gastroschisis comparison group was formed to evaluate trends in I:T ratio in infants undergoing a sepsis evaluation. Infants born between January 1, 2010 and December 31, 2015 were identified based on a gestational age of 30 to 41 weeks, and the collection of a blood culture and CBC, with differential in the first 24 hours of life. No exclusions based on illness severity were made, however, infants were excluded from the de-identified group if they were coded as having an abdominal wall defect (gastroschisis or omphalocele).
A weight-matched comparison cohort was constructed to form an initial set of 462 de-identified control patients, meeting the search criteria by identifying infants whose weight was within 100 g of the weight of the infant with gastroschisis. If multiple infants fell within this criteria, then the infant with the closest weight to the gastroschisis infant was selected for the control group.
Clinical Data
The following clinical data were recorded for each infant: gestational age, birth weight, values of the initial CBC, total white blood cell count (WBC), number of neutrophils, bands, metamyelocytes, myelocytes and promyelocytes, and initial blood culture results. I:T ratios were calculated by adding bands, metamyelocytes, myelocytes, and promyelocytes and dividing this by neutrophils plus the above total. For infants born with gastroschisis, day of life at abdominal closure and type of closure were also recorded.
Antibiotics
The initial length and type of antibiotic treatment for each infant was identified. A broad spectrum course of antibiotics was defined as 5 or more days of treatment with a combination of ampicillin, gentamicin, nafcillin, cefotaxime, piperacillin/ tazobactam, clindamycin, or vancomycin. Prophylactic antibiotic treatment was defined as single drug therapy with either cefazolin or cefoxitin.
Data Analysis
The continuous variables of total WBC, I:T ratio, and antibiotic days were confirmed to be normally distributed, summarized as means, and compared using Student t-test. Evaluations of percentage of infants treated with > 5 days of antibiotics were performed using a chi square analysis. For evaluations using multiple measurements (i.e. comparison of I:T ratio vs. time of abdominal wall closure) a Spearman's rank correlation was calculated and Spearman's ρ coefficient was reported with the corresponding p value. All calculations were performed using Microsoft Excel or SAS 9.3, Cary, North Carolina, USA. A p value of 0.05 was considered statistically significant.
Results
Study Population
A total of 146 infants with gastroschisis were identified, 53 from WPH and 93 from CCHMC. Forty-three infants (one from WPH and 42 from CCHMC) were excluded as initial CBC or blood culture results were not available for review from the transferring hospital (►Fig. 1). Two infants at WPH died on day of life 1, the first from effects of necrotic bowel and the second from multiple congenital anomalies. As both of these infants had a CBC and blood culture drawn on day of life 0, their data was included in the study.
The study set contained 103 infants with gastroschisis. Birth weights ranged from 1250 to 3500 g with a mean birth weight þ/À standard deviation (SD) of 2373 þ/À484 g. Gestational age ranged from 30 to 39 weeks with a mean of 35 þ/À2 weeks.
The weight-matched non-gastroschisis cohort included 103 infants. Birth weight ranged from 1251 to 3500 g with a mean birth weight of 2350 þ/À483 g. Gestational age ranged from 30 to 40 weeks with a mean of 35 þ/À3 weeks (►Table 1).
CBC Results and Associated Blood Cultures
To determine if the CBC is a reliable tool for evaluating early onset infection in infants with gastroschisis, the WBC and I:Tratio were compared between groups. The total WBC in the gastroschisis and non-gastroschisis groups were similar at 14.9 þ/À6 versus There was no correlation between the initial I:T ratio and the gestational age nor the birthweight in the gastroschisis group (Spearman's ρ ¼ 0.16, p ¼ 0.09 and Spearman's ρ ¼ -0.01, p ¼ 0.95, respectively). Likewise, in the control population, there was no correlation between the initial I:T ratio and gestational age or birthweight (Spearman's ρ ¼ 0.07, p ¼ 0.46 and Spearman's ρ ¼ 0.12, p ¼ 0.21, respectively).
Despite the presence of a significantly elevated infection marker in the gastroschisis group, there was no culture positive early onset sepsis in either group.
Incidence of Antibiotic Use
In the gastroschisis group, only one infant did not receive antibiotic therapy with broad spectrum antibiotics compared with 27 infants that did not receive antibiotics in the non-gastroschisis group. The mean exposure to any antibiotics (8.5 þ/À4.9 vs. 1.7 þ/À1.9 days, p < 0.001) and the mean exposure to broad spectrum antibiotics (5.0 þ/À4.3 vs. 1.7 þ /À1.9 days, p < 0.001) were significantly longer in the gastroschisis group.
Seventy seven (75%) of the 103 infants born with gastroschisis received more than 5 days of antibiotics (prophylactic and/or broad spectrum) with 46 (45%) receiving a full course of broad spectrum antibiotics. Of the 44 infants born with gastroschisis who had an I:T ratio greater than 0.2, 29 (66%) infants received > 5 days of broad spectrum antibiotics, while only 17 (29%) of the 59 infants born with gastroschisis who had an I:T ratio less than 0.2 received > 5 days of broad spectrum antibiotics.
In the non-gastroschisis group, only six (6%) infants received more than 5 days of broad spectrum antibiotics. Two (13%) of the 15 infants with I:T ratio greater than 0.2 received a full course of antibiotics. Four (5%) of the 88 infants with I:T ratio less than 0.2 received a full course of antibiotics.
Abdominal Wall Closure
Time of abdominal wall closure was not recorded for eight infants and one infant, who died on day of life one, never had the abdominal wall closed. Sixty infants with gastroschisis were placed in a silo prior to closure. Of the 94 infants with data recorded, time to closure of the abdominal wall, ranged from 0 to 25 days with a mean of 4.3 þ/À3.6 days. There was a negative correlation between the initial I:T value and the time to abdominal wall closure (Spearman's ρ ¼ -0.25, p ¼ 0.015). The mean I:T ratio was higher in gastroschisis infants who subsequently received a primary abdominal wall closure on the first day of life when compared with those who required a staged silo closure (0.24 þ/À0.21 vs. 0.15 þ/À0.18, p ¼ 0.026).
Discussion
In the current study, we evaluated the risk of early onset sepsis and the reliability of the CBC, and I:T ratio in infants with gastroschisis. In addition, we evaluated the antibiotic use trends in this population overall and in relation to the results of the CBC.
Despite the assumed relationship between exposure of the intestines and risk for infection, none of the 103 infants born with gastroschisis were diagnosed with culture positive early onset sepsis.
We found that over a 5-year time period across two hospital systems, 43% of infants born with gastroschisis had an elevated I:T ratio, despite the absence of culture positive bacteremia in all 103 infants. This was significantly increased compared with a group of weight-matched control infants ranging between 30 to 40 weeks gestational age evaluated for early onset sepsis, in which only 15% had an elevated I:T ratio. This data suggests that the I:T ratio is not a reliable marker to determine the presence of early onset culture positive sepsis in infants with gastroschisis. Our results also suggest multiple factors which are inherent to gastroschisis such as surgical closure, bowel ischemia, exposure to amniotic fluid, and other external environmental factors (i.e. exposure of intestines to air, surgical silo, gauze, and manual manipulation) may increase inflammatory markers in these patients in the absence of infection. Furthermore, we saw a negative correlation between I:T ratio and time to abdominal wall closure. The reason for this association is unclear but is counterintuitive to the assumption that infants with larger defects and more externalized bowel would also experience more inflammation. Additionally, the CBC is usually obtained prior to surgical manipulation (e.g., silo or primary closure) which would suggest that surgery itself is not the primary cause of this association. Despite having zero cases of culture positive early onset sepsis, 45% of infants with gastroschisis were exposed to more than 5 days of broad spectrum antibiotics and an additional 30% of infants were exposed to more than 5 days of prophylactic antibiotics. There was also a low incidence of culture positive sepsis in the control group; however, this resulted in only 6% of infants receiving more than 5 days of antibiotics. This level of antibiotic stewardship is not present in the gastroschisis population which brings into question the validity of universal septic evaluation and antibiotic use following delivery in these infants. Additionally, the elevated inflammatory markers in infants with gastroschisis in this study suggest that using the I:T ratio to guide antibiotic therapy is not justified. Despite this limitation, in the gastroschisis infants reviewed, those with an elevated I:T ratio were significantly more likely to receive a full course of broad spectrum antibiotics when compared with gastroschisis infants with a normal I:T ratio.
One major limitation of this study is that it is a retrospective chart review performed at only two hospital systems. While there was an apparent relationship between the abdominal wall defect, elevated I:T ratio, and course of antibiotics in the population studied, the antibiotic trends across the country remain largely unknown. The study population was also small, with only 103 infants with gastroschisis evaluated. Therefore, we may have not had the power to detect a low incidence of early onset sepsis. Due to the retrospective nature of this evaluation, the timing of blood cultures and the amount of blood obtained for culture was unable to be controlled. Our control group was weight-matched to the gastroschisis group; however, due to the increased incidence of intrauterine growth restriction in gastroschisis infants, the resulting gestational age in the control group was slightly lower than in the gastroschisis group.
In conclusion, our study indicates that the risk of early onset sepsis in gastroschisis infants is low and that this risk does not correlate with the I:T ratio. The low risk of early onset infection does not support the increased incidence of early broad spectrum antibiotic use in gastroschisis infants and suggests an opportunity to reduce the exposure to unnecessary antibiotics and antibiotic related complications.
